CAH
41
-7
JPM
62
2
PG
60
7
DE
38
2
BRK.B
56
6
MTB
55
2
PHM
58
5
CB
62
2
HCA
39
4
RIG
47
3
VZ
20
-9
GRMN
58
3
UNH
55
7
MPC
52
13
PYPL
47
2
IPG
61
11
MCO
74
3
EQT
57
7
TSN
38
2
SE
41
8
CAH
41
-7
JPM
62
2
PG
60
7
DE
38
2
BRK.B
56
6
MTB
55
2
PHM
58
5
CB
62
2
HCA
39
4
RIG
47
3
VZ
20
-9
GRMN
58
3
UNH
55
7
MPC
52
13
PYPL
47
2
IPG
61
11
MCO
74
3
EQT
57
7
TSN
38
2
SE
41
8
Financhill
Back

ACADIA Pharmaceuticals Quote, Financials, Valuation and Earnings

He cracked the code to crypto

Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Sell
39

ACAD
ACADIA Pharmaceuticals

Last Price:
16.74
Seasonality Move:
5.15%

7 Day Trial

ALL ACCESS PASS

$ 7

$50 trade to make today with huge potential!

Click here to access my #1 options strategy for overnight wins starting with $50!

ACADIA Pharmaceuticals Price Quote

$16.74
-0.26 (-1.53%)
(Updated: April 23, 2024 at 6:55 PM ET)

ACADIA Pharmaceuticals Key Stats

Sell
39
ACADIA Pharmaceuticals (ACAD) is a Sell
Day range:
$16.94 - $17.34
52-week range:
$16.60 - $33.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.84
P/B ratio:
6.49%
Volume:
940.9K
Avg. volume:
1.9M
1-year change:
-15.38%
Market cap:
$2.8B
Revenue:
$726.4M
EPS:
$-0.38

How Much Does ACADIA Pharmaceuticals Make?

Is ACADIA Pharmaceuticals Growing As A Company?

ACADIA Pharmaceuticals Stock Price Performance

What Is ACADIA Pharmaceuticals 52-Week High & Low?

ACADIA Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ACADIA Pharmaceuticals?

Is ACADIA Pharmaceuticals Cash Flow Positive?

  • What Is ACAD Cash Flow From Operations?
    Cash flow from operations (TTM) is $16.7M
  • What Is ACADIA Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $25.1M
  • What Is ACADIA Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $32M

ACADIA Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    ACAD return on invested capital is -15.6%
  • What Is ACADIA Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -9.38%
  • What Is ACAD Return On Equity?
    ROE is a measure of profitability and is -15.6%

ACADIA Pharmaceuticals Earnings Date & Stock Price

ACADIA Pharmaceuticals Competitors

ACADIA Pharmaceuticals Dividend Yield

Data Unavailable

ACADIA Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -9.51%
Revenue: 69.27% 3.24%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 29.06
Upside from Last Price: 70.96%

Major Shareholders

  • How many ACAD shares are owned by institutional investors?
    259.1M ACAD shares are owned by institutional investors
  • How many ACAD shares are owned by insiders?
    962K ACAD shares are owned by insiders